2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2010
January 26, 2010
Aegera Therapeutics Initiates a Randomized Phase 2 Study with AEG35156 for the Treatment of Hepatocellular Carcinoma
About Aegera
|
Pipeline
|
Clinical Trials
|
Partnerships
|
Media
|
Careers
|
Contact Us
|
Français
© 2009 Aegera Therapeutics Inc. All rights reserved. Developed by
Grafika Designs
.
